AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20553645 — intervention group
Group type: COMPARATOR
Intervention: Ketotifen 0.025 %
Number of subjects: 40
Study 18055312 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 15084997 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursery staff advice and modeling of infant sleep positioning
Number of subjects: 675
Study 15084997 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive supine infant placement advice from nursery staff
Number of subjects: 675
Study 15084997 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine infant placement by mothers
Number of subjects: 675
Study 15084997 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursery staff placement practices
Number of subjects: 675
Study 15084997 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal race/ethnicity
Number of subjects: 675
Study 12236280 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 10357489 — intervention group
Group type: COMPARATOR
Intervention: Metal stent palliation in biliary malignant obstruction (132 patients)
Number of subjects: 4753
Study 10357489 — intervention group
Group type: COMPARATOR
Intervention: Metal stent palliation in esophageal malignant obstruction (82 patients)
Number of subjects: 4753
Study 9082830 — intervention group
Group type: EXPERIMENTAL
Intervention: Microvessel count (MC) assessed using JC70 monoclonal antibody (CD31)
Number of subjects: 68
Study 9082830 — intervention group
Group type: EXPERIMENTAL
Intervention: Microvessel count (MC)
Number of subjects: 68
Study 9082830 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 68
Study 1796618 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 0
Study 1796618 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone-pulse-therapy
Number of subjects: 0
Study 6828842 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (2 X 250 mg)
Number of subjects: 14
Study 6828842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 6828842 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term Acetazolamide therapy
Number of subjects: 14
Study 6828842 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 14
Study 31512954 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model for prognosis
Number of subjects: 0
Study 29452244 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline enema
Number of subjects: 100
Study 29452244 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 100
Study 26254255 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS combined with comprehensive rehabilitation therapy
Number of subjects: 30
Study 26254255 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy combined with comprehensive rehabilitation therapy
Number of subjects: 30
Study 25682193 — intervention group
Group type: EXPERIMENTAL
Intervention: Unannounced hand hygiene reminder signs
Number of subjects: 237
Study 25682193 — intervention group
Group type: COMPARATOR
Intervention: No signs (control)
Number of subjects: 237
Study 23833270 — intervention group
Group type: EXPERIMENTAL
Intervention: (11)C-tariquidar
Number of subjects: 11
Study 23833270 — intervention group
Group type: EXPERIMENTAL
Intervention: (11)C-elacridar
Number of subjects: 11
Study 20068585 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended dairy weight maintenance diet
Number of subjects: 113
Study 20068585 — intervention group
Group type: COMPARATOR
Intervention: Low dairy weight maintenance diet
Number of subjects: 113
Study 20068585 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets (recommended and low dairy)
Number of subjects: 113
Study 18251624 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5-15 mg/day)
Number of subjects: 42
Study 18251624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 16644326 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent
Number of subjects: 101
Study 16644326 — intervention group
Group type: COMPARATOR
Intervention: Bare stent (historical control)
Number of subjects: 101
Study 16644326 — intervention group
Group type: COMPARATOR
Intervention: Cypher stent (historical control)
Number of subjects: 101
Study 12527154 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal patient education program with cognitive‐behavioral stress management training
Number of subjects: 68
Study 12527154 — intervention group
Group type: COMPARATOR
Intervention: Education program without stress management (Control)
Number of subjects: 68
Study 11008913 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 2098
Study 11008913 — intervention group
Group type: COMPARATOR
Intervention: Cytology
Number of subjects: 2098
Study 11008913 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of HPV and LSIL cutpoint
Number of subjects: 2098
Study 9199541 — intervention group
Group type: EXPERIMENTAL
Intervention: linoleic acid (18:2)
Number of subjects: 232
Study 9199541 — intervention group
Group type: EXPERIMENTAL
Intervention: oleic acid (cis‐18:1)
Number of subjects: 232
Study 9199541 — intervention group
Group type: EXPERIMENTAL
Intervention: trans fatty acids (trans‐18:1)
Number of subjects: 232
Study 9199541 — intervention group
Group type: EXPERIMENTAL
Intervention: stearic acid (18:0)
Number of subjects: 232
Study 9199541 — intervention group
Group type: EXPERIMENTAL
Intervention: palmitic acid (16:0)
Number of subjects: 232
Study 9199541 — intervention group
Group type: EXPERIMENTAL
Intervention: myristic acid (14:0)
Number of subjects: 232
Study 9199541 — intervention group
Group type: EXPERIMENTAL
Intervention: mixture of saturated fatty acids (12:0, 14:0, and 16:0)
Number of subjects: 232
Study 1286716 — intervention group
Group type: EXPERIMENTAL
Intervention: Day case surgery
Number of subjects: 442
Study 1286716 — intervention group
Group type: COMPARATOR
Intervention: Inpatient surgery
Number of subjects: 442
Study 3884297 — intervention group
Group type: EXPERIMENTAL
Intervention: Photocoagulation (N = 73)
Number of subjects: 135
Study 3884297 — intervention group
Group type: COMPARATOR
Intervention: Injection sclerotherapy with phenol (N = 62)
Number of subjects: 135
Study 29754402 — intervention group
Group type: EXPERIMENTAL
Intervention: High MAP (70-80 mm Hg)
Number of subjects: 36
Study 29754402 — intervention group
Group type: COMPARATOR
Intervention: Low MAP (40-50 mm Hg)
Number of subjects: 36
Study 29754402 — intervention group
Group type: EXPERIMENTAL
Intervention: High MAP (70-80 mm Hg) for sm AV (<20 μm)
Number of subjects: 36
Study 29754402 — intervention group
Group type: COMPARATOR
Intervention: Low MAP (40-50 mm Hg) for sm AV (<20 μm)
Number of subjects: 36
Study 27916080 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservation of left colonic artery (LCA)
Number of subjects: 97
Study 27916080 — intervention group
Group type: COMPARATOR
Intervention: No preservation of left colonic artery (LCA)
Number of subjects: 97
Study 24155093 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (SB) supplementation at 0.3 g/kg body mass
Number of subjects: 21
Study 24155093 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 21
Study 24155093 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (SB) supplementation
Number of subjects: 21
Study 22473067 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 0
Study 22473067 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 0
Study 20362910 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction method using mandibular right first molar and lateral incisor, and maxillary left central incisor
Number of subjects: 0
Study 20362910 — intervention group
Group type: EXPERIMENTAL
Intervention: New prediction method
Number of subjects: 0
Study 20362910 — intervention group
Group type: COMPARATOR
Intervention: Other methods from the literature
Number of subjects: 0
Study 18408607 — intervention group
Group type: COMPARATOR
Intervention: CHO (0.8 g.kg(‐1)h(‐1) of carbohydrate)
Number of subjects: 6
Study 18408607 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO‐PRO (0.8 g.kg(‐1)h(‐1) of carbohydrate + 0.3 g.kg(‐1)h(‐1) of whey protein isolate)
Number of subjects: 6
Study 16161728 — intervention group
Group type: EXPERIMENTAL
Intervention: Levo‐alpha‐acetylmethadol (LAAM) treatment
Number of subjects: 64
Study 16161728 — intervention group
Group type: COMPARATOR
Intervention: Community treatment referral information only (Control)
Number of subjects: 64
Study 16161728 — intervention group
Group type: COMPARATOR
Intervention: Withdrawn from treatment (Control)
Number of subjects: 64
Study 16161728 — intervention group
Group type: COMPARATOR
Intervention: Control and Withdrawn groups
Number of subjects: 64
Study 14620393 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin therapy
Number of subjects: 0
Study 14620393 — intervention group
Group type: COMPARATOR
Intervention: Blood transfusions
Number of subjects: 0
Study 10992613 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied relaxation
Number of subjects: 0
Study 10992613 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0
Study 10992613 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide sedation
Number of subjects: 0
Study 10992613 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 8777484 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous propafenone
Number of subjects: 0
Study 8777484 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic oral administration of propafenone
Number of subjects: 0
Study 8777484 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 0
Study 8204338 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling (brief psychotherapy)
Number of subjects: 0
Study 3294945 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical minoxidil 2% solution applied twice daily with UVB treatment
Number of subjects: 9
Study 3294945 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical minoxidil 2% solution applied twice daily with PUVA treatment
Number of subjects: 9
Study 3294945 — intervention group
Group type: COMPARATOR
Intervention: Topical minoxidil 2% solution applied twice daily without UVL
Number of subjects: 9
Study 29649309 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir monotherapy (MT)
Number of subjects: 225
Study 29649309 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy (TT)
Number of subjects: 225
Study 27184917 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric Measure of Participation (PMoP) short forms
Number of subjects: 703
Study 26009977 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Decision Support (CDS) intervention
Number of subjects: 7919
Study 26009977 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 7919
Study 24041682 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity endurance-type exercise (45 min, ∼6 METs)
Number of subjects: 20
Study 24041682 — intervention group
Group type: EXPERIMENTAL
Intervention: Activities of daily living (3 bouts of 15 min, ∼3 METs)
Number of subjects: 20
Study 24041682 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control condition
Number of subjects: 20
Study 24041682 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity endurance-type exercise
Number of subjects: 20
Study 24041682 — intervention group
Group type: EXPERIMENTAL
Intervention: Activities of daily living
Number of subjects: 20
Study 21068191 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Self-Management (PSM)
Number of subjects: 517
Study 21068191 — intervention group
Group type: COMPARATOR
Intervention: Routine Care (RC)
Number of subjects: 517
Study 19391534 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp acupuncture with needles retained for 2 hours
Number of subjects: 62
Study 19391534 — intervention group
Group type: COMPARATOR
Intervention: Scalp acupuncture with needles retained for 30 minutes (control group)
Number of subjects: 62
Study 17531401 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole pelvic radiotherapy (WPRT) + Neoadjuvant hormonal therapy (NHT)
Number of subjects: 0
Study 17531401 — intervention group
Group type: COMPARATOR
Intervention: Prostate only radiotherapy (PORT) + Neoadjuvant hormonal therapy (NHT)
Number of subjects: 0
Study 17531401 — intervention group
Group type: COMPARATOR
Intervention: Whole pelvic radiotherapy (WPRT) + Adjuvant hormonal therapy (AHT)
Number of subjects: 0
Study 17531401 — intervention group
Group type: COMPARATOR
Intervention: Prostate only radiotherapy (PORT) + Adjuvant hormonal therapy (AHT)
Number of subjects: 0
Study 17531401 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant hormonal therapy (NHT) + Radiotherapy (RT)
Number of subjects: 0
Study 17531401 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole pelvic radiotherapy (WPRT)
Number of subjects: 0
Study 15345017 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-Cr + polident
Number of subjects: 48
Study 15345017 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-Cr + manipulation
Number of subjects: 48
Study 15345017 — intervention group
Group type: COMPARATOR
Intervention: Co-Cr + water
Number of subjects: 48
Study 15345017 — intervention group
Group type: EXPERIMENTAL
Intervention: Ti-6Al-4V + polident
Number of subjects: 48
Study 15345017 — intervention group
Group type: EXPERIMENTAL
Intervention: Ti-6Al-4V + manipulation
Number of subjects: 48
Study 15345017 — intervention group
Group type: COMPARATOR
Intervention: Ti-6Al-4V + water
Number of subjects: 48
Study 11220039 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated service (community-based rehabilitation officer input)
Number of subjects: 0
Study 11220039 — intervention group
Group type: COMPARATOR
Intervention: Traditional hospital-based optometric service
Number of subjects: 0
Study 11220039 — intervention group
Group type: COMPARATOR
Intervention: Generic community input (non-integrated and not vision specific)
Number of subjects: 0
Study 10901187 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary thymidine glycol excretion after kidney transplantation
Number of subjects: 6
Study 10901187 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteinuria levels after kidney transplantation
Number of subjects: 6
Study 10901187 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel-electrophoretic pattern of proteinuria
Number of subjects: 6
Study 10901187 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymidine glycol excretion levels during different phases
Number of subjects: 6
Study 7706060 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine restraint
Number of subjects: 20
Study 7706060 — intervention group
Group type: COMPARATOR
Intervention: Prone restraint
Number of subjects: 20
Study 2694860 — intervention group
Group type: EXPERIMENTAL
Intervention: Auscultation of the upper abdomen and lungs
Number of subjects: 40
Study 2694860 — intervention group
Group type: EXPERIMENTAL
Intervention: Auscultation of the lungs
Number of subjects: 40
Study 2694860 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction on the tubes with a 60‐ml syringe
Number of subjects: 40
Study 2694860 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation for condensation of water vapor and abnormal movements of the upper abdomen
Number of subjects: 40
Study 15760 — intervention group
Group type: COMPARATOR
Intervention: Beta-adrenoreceptor antagonists (specific drugs not mentioned)
Number of subjects: 25
Study 15760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 31398157 — intervention group
Group type: EXPERIMENTAL
Intervention: No intravenous fluids before surgery (study group, 90 patients)
Number of subjects: 180
Study 31398157 — intervention group
Group type: COMPARATOR
Intervention: 500 ml crystalline intravenous fluids one hour before anaesthesia (control group, 90 patients)
Number of subjects: 180
Study 27485805 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium (0.6mg/kg) injected into a large vein in the antecubital fossa (group A)
Number of subjects: 60
Study 27485805 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium (0.6mg/kg) injected into the vein on the dorsum of the hand (group D)
Number of subjects: 60
Study 25789518 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized pharmacotherapeutic care plan and diabetes education (Intervention Group)
Number of subjects: 70
Study 25789518 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control Group)
Number of subjects: 70
Study 23814850 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP + rIL-2 (1 million IU per day, subcutaneously, days 1-5)
Number of subjects: 109
Study 23814850 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP (standard treatment)
Number of subjects: 109
Study 20633187 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole-based quadruple rescue therapies (RB)
Number of subjects: 190
Study 20633187 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole-based quadruple rescue therapies (EB)
Number of subjects: 190
Study 18230233 — intervention group
Group type: EXPERIMENTAL
Intervention: Written emotional disclosure (ED)
Number of subjects: 0
Study 16634502 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless procedure
Number of subjects: 60
Study 16634502 — intervention group
Group type: COMPARATOR
Intervention: Open-flap procedure
Number of subjects: 60
Study 14594023 — intervention group
Group type: EXPERIMENTAL
Intervention: Leading questions approach
Number of subjects: 595
Study 14594023 — intervention group
Group type: COMPARATOR
Intervention: Neutral questions approach
Number of subjects: 595
Study 14594023 — intervention group
Group type: EXPERIMENTAL
Intervention: Scales incorporating degree of difficulty
Number of subjects: 595
Study 14594023 — intervention group
Group type: EXPERIMENTAL
Intervention: All four approaches (leading, neutral, degree of difficulty, counts of tasks)
Number of subjects: 595
Study 10857840 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost once daily
Number of subjects: 32
Study 10857840 — intervention group
Group type: COMPARATOR
Intervention: 0.5% timolol twice daily
Number of subjects: 32
Study 10857840 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of latanoprost and timolol
Number of subjects: 32
Study 2302935 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline infusion
Number of subjects: 19
Study 2302935 — intervention group
Group type: COMPARATOR
Intervention: Mental stress (CWT)
Number of subjects: 19
Study 2302935 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 19
Study 6994783 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine 1.0 mg and 2.0 mg
Number of subjects: 24
Study 6994783 — intervention group
Group type: COMPARATOR
Intervention: Clonidine 0.15 mg and 0.3 mg
Number of subjects: 24
Study 30295328 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-activated irrigation (LAI) with a 2940 nm Er:YAG-laser (20 Hz, 50 μs, 20 mJ, PIPS tip at the canal entrance)
Number of subjects: 80
Study 30295328 — intervention group
Group type: EXPERIMENTAL
Intervention: Eddy
Number of subjects: 80
Study 30295328 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonically activated irrigation (UAI)
Number of subjects: 80
Study 30295328 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoActivator (EA)
Number of subjects: 80
Study 30295328 — intervention group
Group type: COMPARATOR
Intervention: Needle irrigation (NI)
Number of subjects: 80
Study 30650500 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Chaihu Guizhi Decoction
Number of subjects: 40
Study 30650500 — intervention group
Group type: COMPARATOR
Intervention: Alendronate sodium 70 mg each week
Number of subjects: 40
Study 26687960 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing questions for practice examinations
Number of subjects: 206
Study 26687960 — intervention group
Group type: COMPARATOR
Intervention: Practice test scores, USMLE Step 1 scores, previous ABSITE scores
Number of subjects: 206
Study 25085304 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride delivery system (Opal Seal; Ultradent Products)
Number of subjects: 22
Study 25085304 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Transbond XT; 3M Unitek)
Number of subjects: 22
Study 22309114 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV)
Number of subjects: 650
Study 22309114 — intervention group
Group type: COMPARATOR
Intervention: Nevirapine (NVP)
Number of subjects: 650
Study 19557208 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg once daily added to ICS or ICS/LABA therapy
Number of subjects: 301
Study 18372683 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent artificial gravity (AG) via short radius centrifugation (SRC) for 60 min daily during bed rest
Number of subjects: 8
Study 18372683 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SRC loading)
Number of subjects: 8
Study 15812098 — intervention group
Group type: EXPERIMENTAL
Intervention: Internist involvement in care (intervention group)
Number of subjects: 139
Study 15812098 — intervention group
Group type: COMPARATOR
Intervention: Usual care (usual-care group)
Number of subjects: 139
Study 12059822 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.02 mg.kg(‐1)
Number of subjects: 60
Study 12059822 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 0.25 mg.kg(‐1)
Number of subjects: 60
Study 12059822 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 2 ml (placebo)
Number of subjects: 60
Study 10221441 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 48
Study 10221441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 10221441 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 48
Study 8583658 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone 0.5 mg.kg‐1 administered in the venous reservoir near the end of cardiopulmonary bypass (CPB) and doses of 1 and 5 micrograms.kg‐1.min‐1 by intravenous infusion
Number of subjects: 17
Study 8583658 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone (group C)
Number of subjects: 17
Study 8583658 — intervention group
Group type: COMPARATOR
Intervention: Control group A (no amrinone)
Number of subjects: 17
Study 2749352 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B6 treatment
Number of subjects: 15
Study 2749352 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 15